1032 Locally secreted natural killer cell engager molecules targeting B7-H3 to enhance intratumoral immune response
Nicholas A. Zorko(University of Minnesota Medical Center), Martin Felices(University of Minnesota), Jeffrey S. Miller(Science Museum of Minnesota), Rih‐Sheng Huang(University of Minnesota), Philippa R Kennedy(University of Minnesota), Melissa Khaw(University of Minnesota), Shee Kwan Phung(University of Minnesota), Jacob Rugloski(University of Minnesota), Terran D Stenger(University of Minnesota), Madison Shackelford(University of Minnesota System), Quinlan M. Kile(University of Minnesota)
Cited by 0
Related Papers
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
|Blood|2013|537
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
|Blood|2018|406
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
|Clinical Cancer Research|2018|195